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Abstract
Background: Diagnostic procedures for the diagnosis of infection with the nematode parasite Onchocerca volvulus
are currently based on the microscopic detection of microfilariae in skin biopsies. Alternative approaches based on
amplification of parasitic DNA in these skin biopsies are currently being explored. Mostly this is based on the
detection of the O-150 repeat sequence using PCR based techniques.
Methods: An isothermal, loop-mediated amplification method has been designed using the mitochondrial O.
volvulus cox1 gene as a target.
Results: Analysis of dilution series of synthetic DNA containing the targeted sequence show a non-linear
dose-response curve, as is usually the case for isothermal amplification methods. Evaluation of cross-reactivity
with the heterologous sequence from the closely related parasites Wuchereria bancrofti, Loa loa and Brugia
malayi demonstrated strong specificity, as none of these sequences was amplified. The assay however
amplified both O. volvulus and O. ochengi DNA, but with a different melting point that can be used to
discriminate between the species. Evaluation of this assay in a set of skin snip biopsies collected in an
endemic area in Ghana showed a high correlation with O-150 qPCR and also demonstrated a similar
sensitivity. Compared to qPCR, LAMP had a sensitivity of 88.2% and a specificity of 99.2%.
Conclusions: We have developed a sensitive and specific loop-mediated amplification method for detection
of O. volvulus DNA in skin biopsies that is capable of providing results within 30 min.
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Background
Onchocerciasis, infection with the filarial nematode
Onchocerca volvulus is a neglected tropical disease
which is best known as river blindness [1, 2]. In Africa
at least 120 million people are at risk of infection. The
last comprehensive survey conducted in 2008 indicated
that 26 million people were infected with O. volvulus, of
which 265,000 individuals were blind and 746,000 were
visually impaired. In addition, approximately four mil-
lion people suffer from onchodermatitis with severe itch-
ing [3]. Presently, treatment is based on microfilaricidal
agents, such as ivermectin (Mectizan, Merck), as no
approved macrofilaricide drugs or vaccines are available.
Since microfilaricides only affect the larval stage of O.
volvulus with little or no impact on the adult worm, an-
nual or bi-annual treatments for several years are re-
quired [4, 5]. Since the start of these mass drug
administration programs (MDA) in 1987, ivermectin has
been used to treat hundreds of millions of people with a
resultant reduction in both visual impairment and symp-
tomatic onchodermatitis [6].
Evaluation of MDA programs, and ultimately also
guidance to stop them, is based mainly on monitoring of
infection levels in human populations, as well as in its
vector, the blackfly of the genus Simulium. Besides clin-
ical examination by palpation of nodules formed by
adult worms (macrofilariae), diagnostic tools for
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detection of O. volvulus infection involves finding micro-
filariae (mf) in small, superficial skin biopsy samples
(skin snips) using microscopy [7]. The latter can be a
challenge, especially when larval densities are low, which
is often the case during or the first months after treat-
ment with ivermectin. The sensitivity of this test has
been further increased by using polymerase chain reac-
tion based detection of the Onchocerca specific O-150
repeat sequence [8–11].
Several efforts have been undertaken to identify novel
biomarkers that offer a less-invasive, specific and sensi-
tive marker for infection with O. volvulus [12]. The most
advanced of these tests, is the rapid-format test for the
detection of IgG4 antibodies to the parasitic antigen Ov-
16, which is predominantly useful in a surveillance set-
ting [13–18]. Another approach that has shown promise
is the use of metabolome analysis of serum or urine
samples from infected individuals, which has led to the
identification of urinary N-acetyltyramine-O,β-glucuro-
nide (NATOG) as a unique biomarker for O. volvulus in-
fection [19–21]. More recent work has focused on the
detection of parasitic microRNAs in the blood of in-
fected individuals, but the low levels of these biomarkers
may pose a real challenge to be useful as a diagnostic
marker [22–24].
Isothermal amplification provides a simple process
that rapidly and efficiently accumulates nucleic acids at
constant temperature [25]. In contrast to PCR-based
amplification, no temperature cycles are required, which
facilitates its integration into microsystems or portable
devices. One of the most frequently used isothermal
amplification technologies is the loop mediated isother-
mal amplification (LAMP), which is based on two pri-
mer sets that recognized six different sites on the target
DNA and an optional third set of primers, so-called loop
primers to accelerate the reaction [26, 27]. LAMP offers
advantages over other molecular diagnostic methods be-
cause it is simple, rapid and highly specific. This tech-
nology has been evaluated for the diagnosis of the filarial
parasites Brugia malayi [28], Wuchereria bancrofti [29]
and Loa loa [30–32]. Also for Onchocerca volvulus, a
LAMP assay has been developed for surveillance of
parasite transmission in the blackfly [33].
In the present study, we report the design of a LAMP
assay that targets the mitochondrial encoded O. volvulus
cox1 gene. This work provides evidence of the high sen-
sitivity of this assay, and the close concordance with
qPCR based detection of O. volvulus DNA.
Methods
Study samples
Skin biopsy samples were collected as part of a field
study in Ghana. This study was undertaken in an
Onchocerciasis-endemic community located in Adansi
South District along the Pra River basins in the Ashanti
Region of Ghana. Physical examinations were performed
to identify those subjects having palpable nodules. Most
subjects were participating in MDA programs with iver-
mectin. An overview of the patient demographics is pro-
vided in Table 1. From each participant two skin
biopsies were taken, one from the right and one from
the left hip. Immediately after sampling, biopsies were
transferred individually into a single round bottom well
of a 96-well plate, submerged in saline solution and after
overnight incubation at room temperature each biopsy
was examined microscopically and the emerged microfil-
ariae of O. volvulus counted. [34]. Thereafter the two bi-
opsies collected from each participant were weighed and
transferred individually to microcentrifuge tubes and
stored in liquid nitrogen.
Extraction of genomic DNA from skin biopsies
Genomic DNA was extracted from each skin biopsy
using the OMEGA E.Z.N.A. tissue DNA kit (Norcross,
GA, USA), according to the manufacturer’s instructions.
DNA was eluted in 200 μl elution buffer. The quantity
and quality of extracted DNA was assessed with a Nano-
Drop Spectrophotometer (ND-1000, Thermo Scientific,
Waltham, MA, USA) and DNA was stored at -20 °C be-
fore analysis [34]. Extracted DNA concentrations ranged






No. of subjects 99 51
Age, median (min-max) 47 (21–85) 35 (18–81)
Gender, n (%)
Male 53 (54) 26 (51)
Female 46 (46) 25 (49)
No. of nodules, median (min-max) 1 (1–5) 0
mf status, n (%)
0 mf/mg 89 (90) 51 (100)
0–5 mf/mg 9 (9) 0 (0)
5–10 mf/mg 1 (1) 0 (0)
No. of IVM rounds, median (min-max) 2 (0–10) 0 (0–1)
Time since last treatment
Not treated 16 (16) 34 (67)
< 20 months 68 (69) 5 (10)
> 20 months 15 (15) 12 (24)
Ov16 status, n (%)
Positive 68 (69) 26 (51)
Negative 31 (31) 25 (49)
Abbreviations: mf microfilaria, Ov16 O. volvulus antigen with molecular weight
of 16 kDa
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from 0.2 ng/μl to 134 ng/μl. Extracts were diluted in
nuclease free water to a concentration of 10 ng/μl,
except for those samples which already had a lower
concentration, which were used undiluted. In order to
confirm that DNA in the extracts was intact and
could be amplified, qPCR targeting the human beta-
actin gene was performed on 10 ng of template DNA.
This was done using the PrimeTime actb qPCR assay,
according to the manufacturer’s instructions (Inte-
grated DNA Technologies, Leuven, Belgium). The
primers and probe included in the assay were Fwd
Primer 5'-CAC GGC TAG CTG TG-3', Rev Primer
5'-ATC GTT CGT TGA GCG ATT AGC AG-3',
Probe 5'-6-FAM-GTG GCT CCA TCT TAG CCC
TAG T-IBFQ-3' (Iowa Black® FQ), with internal
quencher ZEN. Four of the 150 extracts (including 1
mf positive sample) were excluded for further analysis
as they did not meet the acceptance criteria described
in the statistical analysis below (see Additional file 1:
Figure S1).
Quantitative real-time PCR assay for detecting O-150 DNA
A TaqMan qPCR assay based on a previously published
method (see [35]) was used to quantify O. volvulus O-150
DNA. The primers and probe included OvFWD 5'-TGT
GGA AAT TCA CCT AAA TAT G-3', OvREV 5'-AAT
AAC TGA TGA CCT ATG ACC-3', OvProbe 5'-6-FAM-
TAG GAC CCA ATT CGA ATG TAT GTA CCC-IBFQ-
3' (Iowa Black® FQ), with internal quencher ZEN (Inte-
grated DNA Technologies, Leuven, Belgium). Taqman
Universal Master Mix without UNG (Applied Biosystems,
P/N 4440040) and nuclease free water were used with all
reactions with the following concentrations and volumes:
1 μl of 10 μM OvFWD, 1 μl of 10 μM OvREV, 2.5 μl of
10 μM OvProbe, 10 μl of 2× Master Mix, 5 μl of template
DNA from extracted skin biopsies, or 2 μl of linearized
Ov-150 positive control plasmid at a concentration of 100
to 106 copies/μl (Integrated DNA Technologies, Leuven,
Belgium), and nuclease-free water was added up to a final
volume of 20 μl. Reactions were performed in duplicate
on a Roche Lightcycler 480 instrument with the following
conditions: 95 °C 10 min (95 °C 15 s, 49 °C 15 s, 60 °C
30 s) × 45 cycles. The second derivate method was used to
calculate Cq values and samples were considered positive
for Ov-150 DNA if Cq (quantification cycle) values were
greater than 36.15 (corresponding to 2 log copies/reac-
tion) in both duplicates. The calibration curve (0.3 to
6.3 log copies/reaction) of the O-150 qPCR assay is
given by the formula y = -3.57x + 43.29 (Additional
file 2: Figure S2).
Loop-mediated isothermal amplification primer design
The complete mitochondrial genome sequence of O. vol-
vulus (NC_001861.1) was retrieved from the NCBI
database. LAMP primers targeting O. volvulus mito-
chondrial DNA were designed using LAMP Designer
V1.13 (OptiGene, Horsham, UK). Two sets of primers
comprising two outer (F3 and B3), and two inner (FIP
and BIP) were selected. FIP contained F1c (complemen-
tary to F1), and the F2 sequence. BIP contained the B1c
sequence (complementary to B1) and the B2 sequence.
Additional loop primers, forward loop primer (LoopF)
and backward loop primer (LoopB) were included in the
reaction. BLAST analysis [36] of the fragment located
between the two outer primers indicated the target gene
was cox1.
Loop-mediated isothermal amplification assay
LAMP reactions were performed using the primers de-
signed as described above. LAMP reactions were per-
formed in a final volume of 25 μl. Reaction mixtures
contained 12 μl Isothermal Mastermix (OptiGene,
Horsham, UK), 0.5 μl of each F3 and B3 primer
(10 μM), 2 μl of each FIP and BIP primer (20 μM), 1 μl
of each LoopF and LoopB (10 μM), 5 μl of template
DNA from extracted skin biopsies, or 5 μl of specific
gBlocks (O. volvulus cox1, O. ochengi cox1, W. bancrofti
cox1, L. loa cox1 or B. malayi cox1) at a concentration
of 100 to 106 copies/μl (Integrated DNA Technologies,
Leuven, Belgium), and nuclease-free water was added up
to a final volume of 25 μl. The mixture was incubated at
65 °C for 45 min, with fluorescent detection every 30 s
on a Roche Lightcycler 480 instrument. At the end of
the incubation period, Tm determination was performed
by increasing the temperature to 95 °C with 5 fluores-
cence acquisitions per °C. The threshold method, using
an arbitrarily selected threshold of 10 RFU, was used to
calculate Ct values. Time to LAMP was calculated by
dividing the obtained Ct values by 2 (one cycle corre-
sponds to 30 s). The detection limit of LAMP was deter-
mined to be 2 log copies/reaction as at this
concentration a positive signal was reproducibly ob-
tained in the assay. Based on the calibration curves ob-
tained with the synthetic DNA and the higher variation
observed in Time to LAMP at low concentrations (2 log
copies/reaction), a cut-off of 30 min was defined. Sam-
ples were considered positive if average Time to LAMP
< 30 min.
Statistical analysis
Results of human Actin qPCR were subjected to statis-
tical analysis in order to identify samples with poor ex-
traction and/or qPCR efficiency. Average Cq value and
standard deviation of all samples was calculated and
possible outliers were identified as samples with Cq
value > average + 2 standard deviations, SD. In case out-
liers were detected, samples were not included for fur-
ther analysis. For comparison of Tm values in different
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groups, a two-tailed unpaired t-test with 95% confidence
interval was performed. P-values < 0.05 were considered
to be significantly different. Correlation between different
parameters was analyzed using linear regression. P-values
were calculated to determine whether slope was signifi-
cantly non-zero and the strength of correlation was deter-
mined using R2-value. All statistical analyses were
performed using GraphPad Prism version 6.02.
Results
A primer set targeting O. volvulus cox1 was designed
using LAMP Designer software (Fig. 1a, b). LAMP as-
says were performed on a dilution series of synthetic
DNA containing the target sequence. Since there is a
close sequence homology with other helminth parasites
(Fig. 1a), assays were also performed on dilution series
of synthetic DNA containing the heterologous sequence
Fig. 1 Design of a LAMP assay targeting O. volvulus cox1. a Alignment of partial gene sequences of cytochrome c oxidase subunit 1 from O.
volvulus, W. bancrofti, L. loa, B. malayi and O. ochengi. b Primer set targeting O. volvulus cox1. c Species-specific LAMP assay targeting O. volvulus
cox1. c Dilution series of gBlocks containing the cox1 fragment of O. volvulus, W. bancrofti, L. loa and B. malayi were used as template in the LAMP
assay using real-time fluorescent dye detection. All samples were analyzed in duplicate. Dilution indicated with an asterisk had detectable signal
in only one of both duplicates
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from Wuchereria bancrofti, Loa loa and Brugia malayi
in order to determine the specificity of the primer set
(Fig. 1c). The region heterologous to the O. volvulus re-
gion targeted by the assay (i.e. from F3 to B3 primer)
was 87.0, 86.7 and 86.2% identical to sequences from W.
bancrofti, L. loa and B. malayi, respectively. When the
O. volvulus target sequence was used as a template, a
clear amplification was observed, with concentration-
dependent time to reach threshold fluorescence signal,
whereas no amplification was observed within the time
interval examined (45 min) when the same amount of
heterologous DNA from W. bancrofti, L. loa or B.
malayi was used.
Specificity of the assay was further investigated by
examining the potential of the primer set to amplify the
heterologous region of O. ochengi. Similarity between
the O. volvulus cox1 and O. ochengi cox1 is very high,
with only 10 nucleotide differences (i.e. 97.5% identity)
over the entire sequence targeted by the assay (Fig. 1a).
Consequently, both synthetic DNA fragments containing
the respective target sequences are amplified with a
similar efficiency and a same time to LAMP as a result
(Fig. 2a). The few nucleotides difference does however
result in a statistically different melting point (Tm).
Mean melt temperatures of 84.14 ± 0.03 and 83.73 ±
0.03 °C for O. volvulus cox1 and O. ochengi cox1, re-
spectively (t(18) = 22.56, P < 0.0001, Fig. 2b), were deter-
mined across 10 reactions. Melting curves obtained on
both DNA fragments were largely overlapping (Fig. 2c).
To demonstrate the applicability of the O. volvulus
cox1 LAMP assay to determine active O. volvulus infec-
tion in individuals living in endemic areas, skin biopsy
samples were collected in the Ashanti Region, an oncho-
cerciasis endemic region in Ghana. A total of 150 indi-
viduals, of which 99 had obvious nodules and 51 had no
signs of onchocerciasis, were included in this study. Of
the 99 nodule-positive individuals, only 10 were found
to contain microfilariae upon microscopic examination.
Total genomic DNA was isolated from these samples.
From the 150 gDNA samples, 4 were excluded as they
did not meet the acceptance criteria (see Methods). The
146 analysed extracts were tested for the presence of O.
volvulus DNA using both qPCR and LAMP (Fig. 3a and
Table 2). While only 9 individuals were found to be test-
positive by microscopy, 17 were positive by qPCR and
15 by LAMP. This observation confirms the superior
sensitivity of molecular detection over microscopic
examination. These data also indicate a sensitivity of
LAMP of 88.2% compared to qPCR (Table 3). The 2
samples negative in LAMP but positive in qPCR had Cq
values of 35 and above, indicating they contained ex-
tremely low amounts of O. volvulus DNA. One sample
that was found to be negative in qPCR was positive in
LAMP, corresponding to a specificity of 99.2% as com-
pared to qPCR. Also, a clear correlation could be ob-
served between Cq values obtained during qPCR and
the Time to LAMP obtained in the LAMP assay (R2 =
0.555, P < 0.001).
Discussion
This work reports the development of a LAMP method
for detection of O. volvulus DNA and its use in field col-
lected skin biopsies from an onchocerciasis endemic re-
gion in Ghana. Currently, diagnosis of infection with O.
volvulus is predominantly based on nodule palpation
and microscopic detection of microfilariae in superficial
skin biopsies [12]. The latter test is particularly useful
for detection of active infection, but consequently suffers
from insufficient sensitivity in an MDA era where the
load of living microfilariae in the skin is dramatically re-
duced [37, 38]. Previous studies already demonstrated
that the detection of O. volvulus DNA using PCR in
such skin biopsies has a higher sensitivity than the clas-
sical microscopy approach [8]. Sensitivity was further
improved by development of a probe-based qPCR assay
[11]. qPCR also has the advantage that it is relatively fast
and is less prone to contamination.
Results presented here demonstrate that similar sensi-
tivities can be achieved with the O. volvulus cox1 LAMP
assay. Only those samples containing very low levels of
Fig. 2 O. volvulus cox1 assay discriminates between O. volvulus and O. ochengi. a Dilution series of gBlocks containing the cox1 fragment
of O. volvulus and O. ochengi were used as template in the O. volvulus cox1 LAMP assay using real-time fluorescent dye detection. b Melting point
determination of the amplicons generated from different dilutions of O. volvulus and O. ochengi template. c Melting curves of the amplicons generated
from O. volvulus and O. ochengi template
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O. volvulus DNA (Cq values in qPCR > 35) were found
to have a negative result in LAMP. Importantly, samples
that were found to be positive upon microscopic exam-
ination were confirmed to be positive using qPCR and
LAMP in eight out of nine cases. Although the O-150
qPCR assay has the advantage of targeting a repeat se-
quence that is present multiple times in the O. volvulus
genome, the cox1 LAMP assay has a comparable clinical
sensitivity of 88.2%. A likely explanation for this high
sensitivity is the fact that the cox1 gene is located in the
mitochondrial genome, while O-150 is located in the nu-
clear genome [39, 40]. Since every cell contains hun-
dreds of mitochondrial DNA copies, it makes
mitochondrial encoded sequences ideal targets for mo-
lecular detection requiring high sensitivity, as is the case
for O. volvulus detection in skin biopsies [41]. For this
reason, the cox1 gene has already been used as a target
for other molecular assays to detect the presence of the
jellyfish Cyanea nozakii in seawater samples or the pres-
ence of the olive tree pest Bactrocera oleae in the guts of
arthropods [42, 43]. It will be of interest for future work
to study whether a correlation exists between number of
mf as determined by microscopy and time to LAMP.
Sample collections from infected, but untreated patients
will be essential for this as these samples should display
a broader range of microfilaremia required to properly
assess such correlation.
The LAMP assay presented here is also shown to be
highly specific for Onchocerca species as no amplifica-
tion could be observed when the heterologous DNA
from W. bancrofti, L. loa and B. malayi were used as
template in the reaction. However, the assay also detects
O. ochengi, but with a slight difference in Tm of the
amplicons produced. As there is a large overlap in the
melting curves obtained for both species, Tm determin-
ation will be able to distinguish both species in case
samples contain only DNA from one of both species but
not in cases were both are present in one and the same
sample. This cross-reactivity with O. ochengi DNA is not
expected to pose an issue when used to analyze skin bi-
opsies from humans as this species is typically present in
cattle and not in humans [44]. As a consequence of this
Fig. 3 Comparison of results obtained by LAMP, O-150 qPCR and microscopic detection of microfilariae in skin snips. Comparison of results obtained
by O. volvulus cox1 LAMP and O-150 qPCR for 146 subjects. Samples that were positive in microscopic examination are indicated in blue (n = 9). For
each quadrant the total number of samples is indicated, as well as the number of microscopy positive samples in parentheses
Table 2 Cross tabulation of results obtained by qPCR, LAMP, microscopic detection of micro-filariae (mf) in skin snips, and nodule
palpation for 146 individuals in the Adansi South District, Ghana
Nodule-positive Nodule-negative
mf-positive mf-negative mf-positive mf-negative Totals
qPCR-positive 8 5 0 4 17
qPCR-negative 1 81 0 47 129
LAMP-positive 8 4 0 4 16
LAMP-negative 1 82 0 47 130
Totals 9 86 0 51 146
Abbreviation: mf microfilariae
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cross-reactivity this assay might not be ideally suited for
specific detection of O. volvulus in Simulium blackfly
vectors where it may be used to assess changes in para-
site prevalence during or after MDA programs [45–49].
The main advantages of isothermal amplification
methods, such as LAMP, over PCR-based detection
techniques, are the speed with which the assays can be
completed, and the simple and relatively inexpensive
equipment required [26, 50]. The O. volvulus cox1
LAMP assay we developed here reaches threshold fluor-
escence after just 10 min in cases of high target concen-
tration and can take up to 30 min for low concentration
samples. This characteristic, together with the availabil-
ity of inexpensive reagents and the possibility to use a
portable real time machine for monitoring the LAMP
amplification, is of great importance for its use for point
of care nucleic acid based diagnosis [51].
One major challenge of the analysis of O. volvulus
DNA skin biopsies remains its invasive nature and the
requirement of extraction techniques to isolate the para-
sitic DNA from this tissue sample [12]. Several efforts
have been undertaken to evaluate simple extraction
methods that are compatible with LAMP, of which boil-
ing in 5% Chelex buffer or in NaOH appear to be the
most promising approaches [52, 53]. Interestingly, ex-
traction and LAMP detection have been integrated in
single devices for detection of e.g. Mycobacterium tuber-
culosis in sputum samples [54]. Whether isolation of O.
volvulus DNA from skin biopsies also can be achieved
with high efficiency using similar extraction methods,
will need to be further investigated.
Conclusions
We have developed a sensitive and specific loop-
mediated amplification method for detection of O.
volvulus DNA in skin biopsies that is capable of pro-
viding results within 30 min.
Additional files
Additional file 1: Figure S1. Cq values of actb qPCR assay on the
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Cq values above this cut-off were excluded in further analyses. (PDF 29 kb)
Additional file 2: Figure S2. Calibration curve of the O-150 qPCR assay.
Calibration samples have been analyzed in 4-fold. Geometric mean and
95% confidence interval are indicated. (PDF 34 kb)
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